Clinical Study of SARS in Children

Epidemiology Clinical Trial

Official title:

Clinical Study of SARS in Children

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00173576
• Other study ID #: 9461700732
• Secondary ID: NSC92-2751-B-002
• Status: Completed
• Phase: N/A
• First received: September 12, 2005
• Last updated: October 26, 2005
• Start date: April 2003
• Est. completion date: March 2005

Study information

• Verified date: August 2005
• Source: National Taiwan University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

Severe acute Respiratory Syndrome (SARS) is an emerging infectious disease. It is caused by a novel SARS-associated coronavirus. According to the epidemiological data, it is highly infectious by intimate contact, respiratory secretion, or direct contact with infectious body fluid. By June 1, 2003, Center for Disease Control Taiwan, R.O.C reported 677 probable SARS cases. Among them, 93.2% (631/677) were more than 20 years old. Only 6.8% (46/677) were under 20 years old. Usually the major hosts of respiratory viruses are children, but evidence up to now shows that SARS is mainly a disease of adults. The data of clinical presentation and epidemiological prevalence in teenage group and children are lacking. Therefore, this project is aimed at the children and teenager among 1 month to eighteen years old. Seroepidemiology of SARS-CoV infection in children would be investigated. Patients who admitted to pediatric wards or visited ER and received blood sampling due to the need of clinical diagnosis/management would be enrolled. After the necessary laboratory examinations were done, the remaining serum would be collected and tested for anti-SARS-CoV IgG by ELISA.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 800
• Est. completion date: March 2005
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 1 Month to 18 Years

Eligibility

Inclusion Criteria:

• Patients aged from 1 month to 18 years old

• Received blood sampling during admission or at emergency department due to the need of clinical diagnosis/management

Exclusion Criteria:

Study Design

Primary Purpose: Screening, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Epidemiology

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
National Taiwan University Hospital	National Science Council, Taiwan